United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the company’s stock in a transaction dated Wednesday, June 17th. The stock was sold at an average price of $552.40, for a total transaction of $5,247,800.00. Following the completion of the transaction, the chief executive officer owned 40,513 shares in […]

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD – Get Free Report) CEO Quang Pham sold 3,613 shares of the company’s stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $3.18, for a total transaction of $11,489.34. Following the completion of the sale, the chief executive officer directly owned 129,102 shares […]

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) General Counsel Jonathan Allan sold 1,457 shares of the stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $29.95, for a total transaction of $43,637.15. Following the transaction, the general counsel owned 18,086 shares of the company’s stock, valued […]

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD – Get Free Report) CEO Quang Pham sold 3,666 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $3.58, for a total transaction of $13,124.28. Following the sale, the chief executive officer owned 132,715 shares in the company, […]

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD – Get Free Report) CEO Quang Pham sold 3,500 shares of the firm’s stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $4.21, for a total value of $14,735.00. Following the completion of the sale, the chief executive officer directly owned 150,839 shares […]

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD – Get Free Report) CEO Quang Pham sold 12,992 shares of the business’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $4.06, for a total transaction of $52,747.52. Following the sale, the chief executive officer directly owned 154,339 shares of the company’s […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $547.62, for a total value of $5,202,390.00. Following the completion of the sale, the chief executive officer owned 40,513 […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) EVP Paul Mahon sold 8,300 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $547.07, for a total value of $4,540,681.00. Following the completion of the sale, the executive vice president owned 45,172 shares in the […]